Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

8.330
-0.120-1.42%
Volume:841.00K
Turnover:6.93M
Market Cap:8.06B
PE:-59.44
High:8.400
Open:8.305
Low:8.120
Close:8.450
52wk High:15.750
52wk Low:6.230
Shares:968.00M
HK Float Shares:968.00M
Volume Ratio:0.89
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.140
ROE:-9.98%
ROA:-5.47%
PB:4.13
PE(LYR):-59.44
PS:13.33

Loading ...

Assessing Alphamab Oncology’s Valuation After JSKN033 Phase II Trial Progress In Advanced Cervical Cancer

Simply Wall St.
·
May 26

ALPHAMAB-B Shares Surge Over 5% on Milestone Enrollment Completion for Envafolimab's New Indication Phase III Trial

Stock News
·
May 22

Alphamab Oncology Expands Share Capital by 0.009 % Through Option Exercise

Bulletin Express
·
May 21

ALPHAMAB-B Issues Shares Following Option Exercise

Stock News
·
May 21

Alphamab Oncology Outlines 12 June 2026 AGM Agenda, Seeks Fresh Share Issuance and Repurchase Mandates

Bulletin Express
·
May 20

Alphamab Oncology Sets 12 June 2026 AGM; Seeks 10% Buy-back and 20% Issuance Mandates, Plans Director Re-elections and Auditor Renewal

Bulletin Express
·
May 20

Alphamab Oncology announces annual general meeting

Reuters
·
May 20

Biotech Stocks Plunge Amid Global Bond Selloff and Rising Interest Rate Concerns

Stock News
·
May 18

Alphamab Oncology Doses First Patient in Phase 2 Study of JSKN033

MT Newswires Live
·
May 13

ALPHAMAB-B (09966) Announces First Patient Dosed in Phase II Study for JSKN033 in First-Line Advanced Cervical Cancer

Stock News
·
May 13

Alphamab Oncology doses first patient in Phase II JSKN033 cervical cancer trial

Reuters
·
May 13

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Alphamab Oncology Maintains Steady Share Base in April 2026, Confirms Adequate Public Float

Bulletin Express
·
May 07

Alphamab Oncology Swings to Loss in 2025

MT Newswires Live
·
Apr 29

ALPHAMAB-B 2025年营收5.66亿元 研发投入攀升至5.72亿元致净亏1.14亿元

Bulletin Express
·
Apr 28

Alphamab Oncology publishes 2025 annual report

Reuters
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

ALPHAMAB-B Grants 250,000 Award Shares to Two Employees

Stock News
·
Apr 23

Alphamab Oncology grants 250,000 restricted share awards to employees under incentive scheme

Reuters
·
Apr 23

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23